Valeant, Ackman Ink Allergan Litigation Management Deal
Valeant Pharmaceuticals International Inc. and William Ackman's hedge fund Pershing Square Capital Management have agreed to split litigation costs in a putative class action over an alleged insider trading scheme in...To view the full article, register now.
Already a subscriber? Click here to view full article